BONE MORPHOGENETIC PROTEINS
- 1 June 2005
- journal article
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 87 (6) , 1367-1378
- https://doi.org/10.2106/00004623-200506000-00027
Abstract
The discovery of bone morphogenetic proteins marks a major step forward in the understanding of bone physiology and in the development of advanced methods in skeletal surgery. The cornerstones for successful growth-factor therapy in skeletal surgery remain biomechanical stability and biological vitality of the bone providing an adequate environment for new bone formation. Knowledge of the biological characteristics, mechanisms of action, and methods of delivery of growth factors will become essential for skeletal surgeons. The current clinical application of bone morphogenetic proteins is safe and efficacious as a result of a well-regulated cascade of events leading to bone formation. Clinical trials have not yet determined whether different clinical indications each require a specific bone-tissue-engineering format or if a single pathway for stimulating bone-healing with growth factors is sufficient.Keywords
This publication has 89 references indexed in Scilit:
- New insights into TGF-β–Smad signallingPublished by Elsevier ,2004
- Disulfide Bridge Conformers of Mature BMP Are Inhibitors for Heterotopic OssificationBiochemical and Biophysical Research Communications, 2001
- Evaluation of recombinant human bone morphogenetic protein‐2 as a bone‐graft substitute in a canine segmental defect modelJournal of Orthopaedic Research, 2000
- The Use of rhBMP-2 in Interbody Fusion CagesSpine, 2000
- Gene-Enhanced Tissue EngineeringAnnals of Plastic Surgery, 1999
- Recombinant bone morphogenetic protein-7 as an intracorporal bone growth stimulator in unstable thoracolumbar burst fractures in humans: preliminary resultsEuropean Spine Journal, 1999
- Potential of porous poly-D,L-lactide-co-glycolide particles as a carrier for recombinant human bone morphogenetic protein-2 during osteoinductionin vivoJournal of Biomedical Materials Research, 1999
- Recombinant human bone morphogenetic protein‐2 is superior to demineralized bone matrix in repairing craniotomy defects in ratsJournal of Biomedical Materials Research, 1994
- Recombinant Vgr-1/BMP-6-expressing tumors induce fibrosis and endochondral bone formation in vivo.The Journal of cell biology, 1994
- Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro.The Journal of cell biology, 1991